Advisory Board and Editors Medical Genetics
Yuan Shang
Dr. Yuan Shang works on Alzheimer's Disease (AD) at the University of Arizona. He combines any potential methods and data to search potential therapeutic opportunities for AD. He is an expert on omics data analysis, multi-omics integrations, network-based pattern recognition, and machine learning-based biomarker discoveries.
Amit Singh
Dr. Singh received his B.Sc. from the Government Degree College Nahan, H.P. University, India and his M.Sc. and Ph.D from Devi Ahilya University, Indore, India. After a short stint as a Research Associate in the field of Trangenics of silkworm, Bombyx mori, in Indian Institute of Sciences (IISc.), Bangalore, India, Dr. Singh moved to Academic Sinica Taiwan to pursue post doctoral research in the field of eye development using Drosophila melanogaster model system. In 2002, Dr. Singh moved to Baylor College of Medicine, Houston, Texas to further pursue his work on Drosophila eye development and was promoted to an instructor (non-tenure track faculty) position in 2004. Dr. Singh was hired at University of Dayton as a tenure track assistant professor in 2007 and promoted to associate professor in 2013. To date, he has published one book and 52 papers.
Kumaravel Somasundaram
Kumar Somasundaram is a Professor at Department of Microbiology Cell Biology, Indian Institute of Science, Bangalore, India. He obtained his Veterinary Medicine degree (1985) from Madras Veterinary College, Masters in Biotechnology (1987) and Ph.D. in bacterial genetics (1993) from Madurai Kamaraj University, Madurai, India. Subsequently, he did his post-doctoral training at Northwestern University and University of Pennsylvania in Cancer Biology before moving to Indian Institute of Science (1999) as a faculty. The major focus of his laboratory is genetics of glioma, the most common primary adult cancer
Monika Stoll
Professor of Genetic Epidemiology at the Medical Faculty and Director of the Leibniz-Institute for Arteriosclerosis Research at the University of Muenster, Germany. Former Associate Editor of Physiological Genomics, Academic Editor of PLoS ONE. Main research interests: Genetics of complex disease traits, in particular cardiovascular and inflammatory diseases; comparative genomics, evolutionary medicine.
Anne Marie Strohecker
Assistant Professor Departments of Cancer Biology and Genetics and Surgery, The Ohio State University
We are interested in mechanisms of autophagy regulation, with a focus on discovering how to modulate the pathway for optimal therapeutic benefit. Current projects are focused on the identification of novel autophagy regulators and their functional relevance for lung tumorigenesis
Ali Torkamani
Dr. Torkamani obtained his undergraduate degree in chemistry at Stanford University, where he received a Bing Foundation Chemistry Research Fellowship, and his doctorate in biomedical sciences at the University of California, San Diego under the mentorship of Dr. Nicholas Schork as an NIH Genetics Predoctoral Training awardee. In 2008, he joined the Scripps Translational Science Institute as a Research Scientist and Donald C. and Elizabeth M. Dickinson Fellow, and shortly thereafter as an Assistant Professor of Molecular and Experimental Medicine and Mario R. Alvarez Fellow. As an Assistant Professor Dr. Torkamani received a Blasker Science and Technology and PhRMA Foundation Award. In 2012, Dr. Torkamani advanced to Director of Genome Informatics at STSI where he leads various human genome sequencing and other genomics initiatives. Dr. Torkamani is also co-founder and Chief Scientific Officer of Cypher Genomics, Inc.
Dr. Torkamani’s research covers a broad range of areas centered on the use of genomic technologies to identify the genetic etiology and underlying mechanisms of human disease in order to define precision therapies for diseased individuals. Major focus areas include human genome interpretation and genetic dissection of novel rare diseases, predictive genomic signatures of response to therapy – especially cancer therapy, and novel sequencing-based assays as biomarkers of disease.
Brett Trost
Dr. Brett Trost is a Scientist in the Molecular Medicine Program at the Hospital for Sick Children, Toronto, Canada. He is a computational biologist with a particular interest in human genetics.
Ece Uzun
Dr. Ece Uzun is the Director of Clinical Bioinformatics at Lifespan Academic Medical Center and Assistant Professor at the Department of Pathology and Laboratory Medicine at Brown University Alpert Medical School. In her clinical work, Dr. Uzun focuses on building bioinformatics analysis pipelines, developing algorithms, tools and databases to aid in clinical variant detection and annotation. In addition to her clinical work, Dr. Uzun's research group develops novel algorithms to analyze big data and gene networks with a focus on complex disorders such as cancer and neurodevelopmental disorders.
Tiziana Vaisitti
Dr. Vaisitti has been working in the field of CLL since she started her PhD program studying the role of CD38 in the biology and pathogenesis of CLL. She continued the training in hematology/oncology obtaining a 3-year fellowship from the Italian Association for Cancer Research (AIRC), with a project aimed at analysing and dissecting the molecular mechanisms regulating leukemic proliferation and homing. Dr. Vaisitti spent several periods in Italian and foreign laboratories as a visiting scientist including a period at Feinstein Institute for Medical Research, North Shore-Long Island Jewish (NY) and a period at the Dept. of Medical Biochemistry and Immunology, Cardiff University (UK). Recently, Dr. Vaisitti spent 2 years as a visiting fellow at the Weill Cornell Medical College, Dept. of Pathology and Laboratory Medicine (NY), to set up patient-derived xenograft models of CLL and Richter syndrome, and also investigate the functional impact of novel drugs.
In the last 5 years, Dr. Vaisitti’s research has been focused on two main topics. The first one is the functional analysis of genes found recurrently mutated in chronic lymphoproliferative syndromes. Attention has been focused on NOTCH1, SF3B1, BIRC3 and NOTCH2. These works were done in a joint collaboration with the group of Prof. Gaidano (University of Eastern Piedmont, Italy). The second topic is the discovery and analysis of host microenvironmental conditions that favor leukemic development and progression.
Ranjit Vijayan
Dr. Ranjit Vijayan obtained his PhD in Life Sciences Interface/Biochemistry from the University of Oxford, UK, and his DipGrad in Management from the London School of Economics & Political Science, University of London, UK. In 2004 Dr Vijayan obtained his MSc in Computer Science from the University of Wales, Aberystwyth, UK, and prior to this his BEng in Electrical & Electronic Engineering, Nanyang Technological University, Singapore.
Dr. Vijayan's research interests include; molecular dynamics simulations of biological macromolecules, protein structure modeling, structure based drug discovery, genomics & transcriptomics, pharmacogenomics and high-performance computing.
Shibiao Wan
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy, and the Assistant Director for Bioinformatics and Systems Biology Core at University of Nebraska Medical Center (UNMC). He is also an Assistant Professor (courtesy) in the Department of Biostatistics at UNMC.
With more than 14 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >50 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals including Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Biology, Frontiers in Genetics, and Genes.
Dr Wan is a TPC member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >50 prestigious journals including Nature Methods, Nature Communications, Nature Computational Science, Nucleic Acids Research, Cancer Research, Genome Medicine, and Briefings in Bioinformatics. Dr. Wan has received a number of accolades including the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 awarded by Clarivate. Dr. Wan is a member of AACR, ISCB and ACM and an IEEE Senior Member.
Albert HC Wong
Albert H.C. Wong is a neuroscientist and psychiatrist at the Centre for Addiction and Mental Health, and a Professor at the University of Toronto. He attended medical school at the University of Toronto, where he also completed specialty training in psychiatry and a PhD in neurobiology. Dr. Wong’s lab uses animal models and clinical studies to investigate genetic, epigenetic and developmental mechanisms of psychiatric disease. His areas of clinical expertise are in schizophrenia and brain stimulation.